Overview

Epidiolex and Drug Resistant Epilepsy in Children

Status:
Available
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
This open-label, multi-center study is open to patients 1 to 18 years of age at time of enrollment with medication resistant epilepsy.
Details
Lead Sponsor:
Augusta University
Collaborator:
State of Georgia
Treatments:
Cannabidiol